TRIM34通过诱导mTORC1-依赖的葡萄糖利用和促进细胞死亡来抑制非小细胞肺癌
Pengfei Zhang1, Zhida Chen2, Juan Li3
1Chinese PLA Medical School, Beijing, 100853, China; Department of Oncology, First Medical Center of Chinese PLA General Hospital, Beijing, 100853, China.
Archives of biochemistry and biophysics
|February 9, 2024
概括
研究发现,TRIM34是一种蛋白质,通过破坏线粒体和促进细胞死亡来抑制非小细胞肺癌 (NSCLC) 的进展. 较低的TRIM34水平与NSCLC相关,表明其作为治疗生物标志物的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 非小细胞肺癌 (NSCLC) 是癌症死亡的主要原因.
- TRIM34在NSCLC发病过程中的作用以前没有被研究过.
- 众所周知,TRIM34可以影响亡和炎症.
研究的目的:
- 研究TRIM34在NSCLC中的调控作用.
- 确定TRIM34在NSCLC中的作用背后的分子机制.
主要方法:
- 在NSCLC组织中分析TRIM34表达水平.
- 在体外和体内实验中评估TRIM34过度表达对NSCLC细胞的影响.
- 利用mTORC1抑制剂拉巴素来研究途径的参与.
主要成果:
- 发现TRIM34表达在NSCLC中受到下调.
- 在NSCLC细胞中,TRIM34过度表达诱导了线粒体损伤和亡.
- TRIM34激活了mTORC1信号,导致加速糖解和抑制瘤的进展.
- 拉帕米辛治疗逆转了TRIM34过度表达对线粒体损伤和亡的影响.
结论:
- TRIM34通过激活mTORC1-依赖的葡萄糖代谢并促进细胞死亡,作为NSCLC中的瘤抑制剂.
- TRIM34有可能成为NSCLC患者的治疗生物标志物.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Replicative Cell Senescence
3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K


